XML 85 R55.htm IDEA: XBRL DOCUMENT v3.24.0.1
Acquisitions and divestitures - Summary of Total Consideration for Horizon Therapeutics plc (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Oct. 06, 2023
Dec. 31, 2022
Dec. 31, 2021
Business Acquisition [Line Items]        
Goodwill $ 18,629   $ 15,529 $ 14,890
Horizon Therapeutics        
Business Acquisition [Line Items]        
Cash and cash equivalents   $ 681    
Inventories $ 5,000 5,025    
Property, plant and equipment, net   318    
Acquired in-process research and development   1,060    
Goodwill   3,111    
Deferred tax asset   834    
Deferred tax liability, net   (2,492)    
Other liabilities, net   (294)    
Total assets acquired, net   27,833    
Horizon Therapeutics | Developed-product-technology rights        
Business Acquisition [Line Items]        
Finite-lived intangible assets – developed-product-technology rights   $ 19,590